Specifically, fasting glucose (p = 0.026, 95% CI 0.03, 0.61, d = 0.71) and insulin concentrations (p = 0.013, 95% CI 4.4, 28.9, d = 0.97) were reduced by 6% and 14%, respectively, resulting in lower insulin resistance (HOMA-IR p = 0.007, 95% CI 0.12, 0.56, d = 1.09) and increased insulin sensitivity (Matsuda p = 0.014, 95% CI −0.62, −0.09, d = 0.98). The gene discussed is INS; the disease is Insulin resistance.